An engineered VEGF-activating zinc finger protein transcription factor improves blood flow and limb salvage in advanced-age mice.
about
Systems biology of pro-angiogenic therapies targeting the VEGF systemLimb ischemia after iliac ligation in aged mice stimulates angiogenesis without arteriogenesis.Delayed administration of a bio-engineered zinc-finger VEGF-A gene therapy is neuroprotective and attenuates allodynia following traumatic spinal cord injury.VEGF gene therapy fails to improve perfusion of ischemic myocardium in patients with advanced coronary disease: results of the NORTHERN trialManipulating the microvasculature and its microenvironment.Effects of aging on angiogenesis.Pericytes: multitasking cells in the regeneration of injured, diseased, and aged skeletal muscle.Neuroprotection using gene therapy to induce vascular endothelial growth factor-A expressionAging causes collateral rarefaction and increased severity of ischemic injury in multiple tissues.Endothelial-derived neuregulin is an important mediator of ischaemia-induced angiogenesis and arteriogenesisCardiovascular gene therapy: current status and therapeutic potential.Gene expression profiling of peripheral blood mononuclear cells in the setting of peripheral arterial disease.Engineered zinc-finger proteins can compensate genetic haploinsufficiency by transcriptional activation of the wild-type allele: application to Willams-Beuren syndrome and supravalvular aortic stenosisMechanisms and treatment of cardiovascular disease in Williams-Beuren syndrome.Engineered zinc finger protein-mediated VEGF-a activation restores deficient VEGF-a in sensory neurons in experimental diabetes.Vascular endothelial growth factor-A specifies formation of native collaterals and regulates collateral growth in ischemia.
P2860
Q30430112-8D4D0B95-62A0-4910-89EB-F934DFB133A5Q30486693-51F6A9A5-1C15-49E1-A5A7-03DB03D1BD74Q33638148-175ABCAE-614D-46F4-A7C8-159076FD2DF2Q33713721-0021C9A9-B72E-4FC4-861E-6147B3540984Q33893860-EF042704-AE17-43BA-908E-646711DC0223Q33914406-673357EF-06FC-49DB-9D3A-39BA2F3AF2AEQ34201678-DB596F1C-780A-4C35-8B3F-4D46356C83C7Q34430669-AABC05D5-A6EC-4646-A446-3ADBD1917F70Q35120340-F9F1C6E9-821C-4763-A1C6-E1E0D5077423Q35766061-27B5304F-78E5-43CB-8032-8F444B225DB5Q35995220-65645434-42F6-4C17-949D-2C8F4708F4B3Q36054090-37FA539D-86EE-4163-8393-3A3396EA5E8BQ36401362-D240E8F2-10C5-4206-B21B-584084377CC1Q37152735-C95C41A6-531E-4192-872C-A18F91FE23F3Q41977443-A55D756E-455B-4E03-9CF5-CF32A9C30F06Q42734729-B6C6B03B-A198-4298-8C97-CA5BD9E982A4
P2860
An engineered VEGF-activating zinc finger protein transcription factor improves blood flow and limb salvage in advanced-age mice.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
An engineered VEGF-activating ...... salvage in advanced-age mice.
@ast
An engineered VEGF-activating ...... salvage in advanced-age mice.
@en
type
label
An engineered VEGF-activating ...... salvage in advanced-age mice.
@ast
An engineered VEGF-activating ...... salvage in advanced-age mice.
@en
prefLabel
An engineered VEGF-activating ...... salvage in advanced-age mice.
@ast
An engineered VEGF-activating ...... salvage in advanced-age mice.
@en
P2093
P356
P1433
P1476
An engineered VEGF-activating ...... salvage in advanced-age mice.
@en
P2093
Casey Case
Dinggang Liu
Edward Rebar
Frank J Giordano
Jennifer L Yeh
Kaye Spratt
Linda Hinh
Reed P Hickey
P304
P356
10.1096/FJ.04-3670FJE
P407
P577
2006-01-19T00:00:00Z